Genetic predisposition for vitamin D deficiency is not associated with adverse outcome of very low birth weight infants: A cohort study from the German Neonatal Network.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 01 10 2019
accepted: 28 02 2020
entrez: 2 4 2020
pubmed: 2 4 2020
medline: 26 6 2020
Statut: epublish

Résumé

Postnatal vitamin D supplementation is standard of care in neonates and preterm infants. Despite routine supplementation of vitamin D, a wide range of complications related to vitamin D deficiency has been described in the literature. Since standard vitamin D supplementation might be not sufficient in preterm infants with a genetic predisposition for vitamin D deficiency, we investigated the outcome of preterm infants with regard to their genetic estimated vitamin D levels. Preterm infants with a birth weight below 1500 grams were included in the German Neonatal Network at the time of their birth and tested at the age of five. The vitamin D level was genetically calculated based on three single nucleotide polymorphisms (SNPs: rs12794714, rs7944926 and rs2282679) which alter vitamin D synthesis pathways. Specific alleles of these polymorphisms are validated markers for low plasma vitamin D levels. Outcome data were based on baseline data at the time of birth, typical complications of prematurity, body measurements at the age of five and occurrence of bone fractures. T-test and Fisher's exact test were used for statistical comparison. According to their genetic predisposition, 1,924 preterm infants were divided into groups of low (gsVitD < 20. Percentile), intermediate and high vitamin D level estimates. Low genetic vitamin D level estimates could not be shown to be associated with any adverse outcome measures examined. The analyses covered data on aforementioned determinants. Low genetic vitamin D level estimates could not be shown to be associated with previously described adverse outcome in preterm infants.

Identifiants

pubmed: 32231377
doi: 10.1371/journal.pone.0230426
pii: PONE-D-19-27510
pmc: PMC7108707
doi:

Substances chimiques

Vitamin D 1406-16-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0230426

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

N Engl J Med. 2018 Aug 09;379(6):535-546
pubmed: 30089075
Curr Opin Allergy Clin Immunol. 2009 Jun;9(3):202-7
pubmed: 19365260
Br J Nutr. 2010 Jul;104(1):108-17
pubmed: 20193097
Lancet. 2012 Jun 9;379(9832):2162-72
pubmed: 22682464
BMJ. 2014 Apr 01;348:g1903
pubmed: 24690623
PLoS Med. 2015 Aug 25;12(8):e1001866
pubmed: 26305103
PLoS One. 2018 Dec 19;13(12):e0208033
pubmed: 30566429
Acta Paediatr. 2017 Sep;106(9):1409-1437
pubmed: 28419544
BMJ. 2014 Nov 18;349:g6330
pubmed: 25406188
Z Geburtshilfe Neonatol. 2012 Oct;216(5):212-9
pubmed: 23108965
Nat Commun. 2018 Jan 17;9(1):260
pubmed: 29343764
Lancet. 2010 Jul 17;376(9736):180-8
pubmed: 20541252
Iran J Pediatr. 2014 Apr;24(2):191-7
pubmed: 25535539
Int J Epidemiol. 2016 Oct;45(5):1619-1630
pubmed: 27594614
Clin Chim Acta. 2010 Sep 6;411(17-18):1354-60
pubmed: 20515678
J Child Neurol. 2016 Apr;31(5):603-12
pubmed: 26385973
Lancet Diabetes Endocrinol. 2014 Sep;2(9):719-29
pubmed: 24974252
Stroke. 2015 Jan;46(1):248-51
pubmed: 25424481
Am J Respir Crit Care Med. 2001 Jun;163(7):1723-9
pubmed: 11401896
J Clin Invest. 2006 Aug;116(8):2062-72
pubmed: 16886050
J Nutr. 2010 May;140(5):999-1006
pubmed: 20200114
Rev Endocr Metab Disord. 2017 Jun;18(2):153-165
pubmed: 28516265
Int J Mol Sci. 2014 Apr 17;15(4):6569-91
pubmed: 24747593
Arq Bras Endocrinol Metabol. 2014 Feb;58(1):1-8
pubmed: 24728158
Am J Epidemiol. 2017 Jun 15;185(12):1255-1262
pubmed: 28459987
J Bone Miner Res. 2013 Aug;28(8):1784-92
pubmed: 23505139
N Engl J Med. 2019 Jan 3;380(1):33-44
pubmed: 30415629

Auteurs

Clara Mannhardt (C)

Department of Pediatrics, University of Lübeck, Lübeck, Germany.

Tanja K Rausch (TK)

Department of Pediatrics, University of Lübeck, Lübeck, Germany.
Institute of Medical Biometrics and Statistics, University of Lübeck, Lübeck, Germany.

Mats Ingmar Fortmann (MI)

Department of Pediatrics, University of Lübeck, Lübeck, Germany.

Isabelle Swoboda (I)

Department of Pediatrics, University of Lübeck, Lübeck, Germany.

Alexander Humberg (A)

Department of Pediatrics, University of Lübeck, Lübeck, Germany.

Juliane Spiegler (J)

Department of Pediatrics, University of Lübeck, Lübeck, Germany.

Wolfgang Göpel (W)

Department of Pediatrics, University of Lübeck, Lübeck, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH